Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Smalling

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Circulation|July 1, 1992
Redoubtable restenosisR W Smalling
The American Journal of Cardiology|December 19, 1996
Molecular biology of plasminogen activators: what are the clinical implications of drug design?R W Smalling
The Journal of Invasive Cardiology|July 18, 2001
Fibrinolytic monotherapy for acute myocardial infarctionR W Smalling
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1983
The SPECTrum of thallium-201 imaging in coronary artery diseaseR W Smalling
Herz|February 1, 1986
Changes in ventricular function associated with coronary reperfusion in acute myocardial infarctionR W Smalling
Journal of the American College of Cardiology|August 1, 1987
Can the immediate efficacy of coronary angioplasty be adequately assessed?R W Smalling
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 16, 1997
A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomesR W Smalling
European Heart Journal|February 3, 1998
Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activatorR W Smalling
Catheterization and Cardiovascular Diagnosis|November 1, 1994
Transstenotic pressures: can there be a "low-tech" solution to a complex physiologic problem?R W Smalling
Texas Heart Institute Journal|January 1, 1991
The use of mechanical assist devices in the management of cardiogenic shock. Secondary to acute myocardial infarctionR W Smalling
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Circulation|July 1, 1992
Redoubtable restenosisR W Smalling
The American Journal of Cardiology|December 19, 1996
Molecular biology of plasminogen activators: what are the clinical implications of drug design?R W Smalling
The Journal of Invasive Cardiology|July 18, 2001
Fibrinolytic monotherapy for acute myocardial infarctionR W Smalling
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1983
The SPECTrum of thallium-201 imaging in coronary artery diseaseR W Smalling
Herz|February 1, 1986
Changes in ventricular function associated with coronary reperfusion in acute myocardial infarctionR W Smalling
Journal of the American College of Cardiology|August 1, 1987
Can the immediate efficacy of coronary angioplasty be adequately assessed?R W Smalling
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 16, 1997
A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomesR W Smalling
European Heart Journal|February 3, 1998
Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activatorR W Smalling
Catheterization and Cardiovascular Diagnosis|November 1, 1994
Transstenotic pressures: can there be a "low-tech" solution to a complex physiologic problem?R W Smalling
Texas Heart Institute Journal|January 1, 1991
The use of mechanical assist devices in the management of cardiogenic shock. Secondary to acute myocardial infarctionR W Smalling
Pageof 10